FT ENEMA READY TO USE
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMStrength
7; 19 g/118mL; g/118mL
Manufacturer
McKessonNDC
70677108901
Classification
Generic
Dosage Form
ENEMA
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
5/2/2023
Price Statistics
The NADAC for FT ENEMA READY TO USE has been published 113 times since Aug 7, 2024, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0067 per ML |
|---|---|
| All-time high | $0.0093 (Feb 12, 2025) |
| All-time low | $0.0062 (Jul 22, 2026) |
| 52-week high | $0.0077 |
| 52-week low | $0.0062 |
| Median price | $0.0080 |
| Average price | $0.0076 |
| Largest weekly change | -8.2% (Oct 22, 2025) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ENEMA READY TO USE?
The current National Average Drug Acquisition Cost (NADAC) for FT ENEMA READY TO USE, manufactured by McKesson, is $0.0067 per ML (NDC 70677108901), effective Sep 30, 2026.
How has the price of FT ENEMA READY TO USE changed over time?
Over the history we have for it, the NADAC for FT ENEMA READY TO USE has declined 19.0%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FT ENEMA READY TO USE?
Since Aug 7, 2024, the NADAC for FT ENEMA READY TO USE has ranged from a low of $0.0062 (Jul 22, 2026) to a high of $0.0093 (Feb 12, 2025), with a median of $0.0080 per ML.
Are there cheaper alternatives to FT ENEMA READY TO USE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT ENEMA READY TO USE in a comparable dosage form, but none are currently priced below it.
Who manufactures FT ENEMA READY TO USE?
FT ENEMA READY TO USE (NDC 70677108901) is labeled by McKesson, and CMS classifies it as a generic product.